Kevin Chapman
Consultant / Advisor at Celesta Global Capital Managers LLC
Profile
Kevin Chapman is currently working as an Advisor at Celesta Global Capital Managers LLC and as the Chief Scientific Officer at Prellis Biologics, Inc. He previously worked as a Senior Director at Pacific Bioscience Laboratories, Inc. from 2010 to 2012 and as the Chief Scientific Officer at Berkeley Lights, Inc. He completed his undergraduate degree from the University of California, Los Angeles.
Kevin Chapman active positions
| Companies | Position | Start |
|---|---|---|
Celesta Global Capital Managers LLC
 Celesta Global Capital Managers LLC Investment ManagersFinance Celesta Global Capital Managers LLC (Celesta Capital) is a venture capital firm founded in 2013 by Michael Marks, Nicholas Brathwaite, Sriram Viswanathan and Lip-Bu Tan. The firm is headquartered in San Francisco, California. | Consultant / Advisor | - |
Prellis Biologics, Inc.
 Prellis Biologics, Inc. BiotechnologyHealth Technology Prellis Biologics, Inc. engages in building human tissues for drug development, and also develops human organs for transplantation. It offers vascularized tissue, bio and human organ printing. The firm's products include Organoid, Vascular Bundle, 3D Tissue Chip, Cell Seeding Matrix, Cell Adhesion Plus and Holograph-X Bioprinter. The company was founded by Noelle Huskey Mullin and Melanie Matheu in October 2016 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | 2021-06-30 |
Former positions of Kevin Chapman
| Companies | Position | End |
|---|---|---|
Pacific Bioscience Laboratories, Inc.
 Pacific Bioscience Laboratories, Inc. Medical/Nursing ServicesHealth Services Pacific Bioscience Laboratories Inc. engages in the development of health and skin care products. It offers face brushes, crush heads, and face cleaners. It operates under the Clarisonic brand. The company was founded by Dr. Robert E. Akridge, David Giuliani and Kenneth A. Pilcher in 2001 and is headquartered in Bellevue, WA. | Corporate Officer/Principal | 2012-01-31 |
Berkeley Lights, Inc.
 Berkeley Lights, Inc. Packaged SoftwareTechnology Services Berkeley Lights, Inc. engages in rapid development and commercialization of biotherapeutics and other cell-based products. Its platform captures deep phenotypic, functional and genotypic information for tens of thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. It operates through the following geographical segments: North America, Asia Pacific, and Europe. The company was founded by Igor Y. Khandros, William H. Davidow, Michael E. Marks, and Ming C. Wu on April 5, 2011 and is headquartered in Emeryville, CA. | Corporate Officer/Principal | - |
Training of Kevin Chapman
| University of California, Los Angeles | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Pacific Bioscience Laboratories, Inc.
Pacific Bioscience Laboratories, Inc. Medical/Nursing ServicesHealth Services Pacific Bioscience Laboratories Inc. engages in the development of health and skin care products. It offers face brushes, crush heads, and face cleaners. It operates under the Clarisonic brand. The company was founded by Dr. Robert E. Akridge, David Giuliani and Kenneth A. Pilcher in 2001 and is headquartered in Bellevue, WA. | Health Services |
Celesta Global Capital Managers LLC
Celesta Global Capital Managers LLC Investment ManagersFinance Celesta Global Capital Managers LLC (Celesta Capital) is a venture capital firm founded in 2013 by Michael Marks, Nicholas Brathwaite, Sriram Viswanathan and Lip-Bu Tan. The firm is headquartered in San Francisco, California. | Finance |
Berkeley Lights, Inc.
Berkeley Lights, Inc. Packaged SoftwareTechnology Services Berkeley Lights, Inc. engages in rapid development and commercialization of biotherapeutics and other cell-based products. Its platform captures deep phenotypic, functional and genotypic information for tens of thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. It operates through the following geographical segments: North America, Asia Pacific, and Europe. The company was founded by Igor Y. Khandros, William H. Davidow, Michael E. Marks, and Ming C. Wu on April 5, 2011 and is headquartered in Emeryville, CA. | Technology Services |
Prellis Biologics, Inc.
Prellis Biologics, Inc. BiotechnologyHealth Technology Prellis Biologics, Inc. engages in building human tissues for drug development, and also develops human organs for transplantation. It offers vascularized tissue, bio and human organ printing. The firm's products include Organoid, Vascular Bundle, 3D Tissue Chip, Cell Seeding Matrix, Cell Adhesion Plus and Holograph-X Bioprinter. The company was founded by Noelle Huskey Mullin and Melanie Matheu in October 2016 and is headquartered in San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Kevin Chapman
